Cargando…

Health state utilities associated with treatment for transfusion-dependent β-thalassemia

OBJECTIVES: Transfusion-dependent β-thalassemia (TDT) is a genetic disease that affects production of red blood cells. Conventional treatment involves regular red blood cell transfusions and iron chelation, which has a substantial impact on quality of life. While potentially curative, allogeneic hem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matza, Louis S., Paramore, L. Clark, Stewart, Katie D., Karn, Hayley, Jobanputra, Minesh, Dietz, Andrew C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188724/ https://www.ncbi.nlm.nih.gov/pubmed/31828456 http://dx.doi.org/10.1007/s10198-019-01136-0

Ejemplares similares

Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia
por: Kansal, Anuraag R., et al.
Publicado: (2021)

Patient- and Caregiver-Reported Burden of Transfusion-Dependent β-Thalassemia Measured Using a Digital Application
por: Paramore, Clark, et al.
Publicado: (2020)

Routine management, healthcare resource use and patient and carer‐reported outcomes of patients with transfusion‐dependent β‐thalassaemia in the United Kingdom: A mixed methods observational study
por: Shah, Farrukh, et al.
Publicado: (2021)

A review of the economic burden of ADHD
por: Matza, Louis S, et al.
Publicado: (2005)

Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
por: Bordbar, Mohammad Reza, et al.
Publicado: (2014)

β-Thalassemia Mutations among Transfusion-Dependent Thalassemia Major Patients in Northern Iraq
por: Al-Allawi, Nasir A. S., et al.
Publicado: (2010)

Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy
por: Matza, Louis S., et al.
Publicado: (2019)

Luspatercept for transfusion-dependent β-thalassemia: time to get real
por: Musallam, Khaled M., et al.
Publicado: (2023)

How I treat non-transfusion-dependent β-thalassemia
por: Saliba, Antoine N., et al.
Publicado: (2023)

Molecular Analysis of Non-Transfusion Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia Disease without α-Thalassemia
por: Phanrahan, Paramee, et al.
Publicado: (2019)

Pulmonary Functions in Transfusion-Dependent Thalassemia
por: Chandra, Jagdish, et al.
Publicado: (2022)

S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
por: Locatelli, Franco, et al.
Publicado: (2023)

Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2020)

Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia
por: Haghpanah, Sezaneh, et al.
Publicado: (2022)

Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
por: Matza, Louis S., et al.
Publicado: (2017)

Alloimmunization among transfusion-dependent thalassemia patients
por: Sadeghian, Mohammad Hadi, et al.
Publicado: (2009)

Glomerular and Tubular Functions in Transfusion-Dependent Thalassemia
por: Sookaromdee, Pathum, et al.
Publicado: (2018)

Quality of life in transfusion-dependent thalassemia patients
por: Alzahrani, Rizqallah A., et al.
Publicado: (2017)

Hypoparathyroidism in a Case of Transfusion Dependent Thalassemia
por: Majumder, Anirban, et al.
Publicado: (2020)

Renal Hemosiderosis among Iranian Transfusion Dependent β-Thalassemia Major Patients
por: Hashemieh, Mozhgan, et al.
Publicado: (2017)

The transfusion management of beta thalassemia in the United States
por: Lal, Ashutosh, et al.
Publicado: (2021)

P1703: ECONOMIC BURDEN OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN THE UNITED STATES
por: Udeze, C., et al.
Publicado: (2022)

Hemorheological profiles and chronic inflammation markers in transfusion-dependent and non-transfusion- dependent thalassemia
por: Caprari, Patrizia, et al.
Publicado: (2023)

Comprehensive patient care improves quality of life in transfusion dependent patients with β-thalassemia
por: Ali, Salah S., et al.
Publicado: (2015)

Complications of Transfusion-Dependent β-Thalassemia Patients in Sistan and Baluchistan, South-East of Iran
por: Yaghobi, Maryam, et al.
Publicado: (2017)

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia
por: Musallam, Khaled M., et al.
Publicado: (2021)

Efficacy of Hydroxyurea in Transfusion-Dependent Major β-Thalassemia Patients: A Meta-Analysis
por: Hatamleh, Modather I, et al.
Publicado: (2023)

Osteoporosis-osteopenia syndrome in children with transfusion dependent thalassemia
por: Ong, Zhi-Miin, et al.
Publicado: (2015)

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
por: Sleiman, Joseph, et al.
Publicado: (2018)

Leukocyte telomere length in patients with transfusion-dependent thalassemia
por: Nanthatanti, Nithita, et al.
Publicado: (2020)

Occult Kidney Dysfunction in Children With Transfusion-Dependent Thalassemia
por: Mohd Zikre, Nurwahida, et al.
Publicado: (2021)

Non-Transfusion-Dependent Thalassemia: A Panoramic Review
por: Shash, Hwazen
Publicado: (2022)

Mutational analysis of thalassemia in transfusion-dependent beta-thalassemia patients from central India
por: Shrivastava, Manisha, et al.
Publicado: (2019)

Marital status and paternity in patients with Transfusion-Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries
por: De Sanctis, Vincenzo, et al.
Publicado: (2019)

EQ-5D-3L health state utility values in transfusion-dependent thalassemia patients in Malaysia: a cross-sectional assessment
por: Shafie, Asrul Akmal, et al.
Publicado: (2021)

The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent β-thalassemia in Taiwan
por: Chang, Hsiu-Hao, et al.
Publicado: (2015)

Protocol for extramedullary hematopoiesis in patients with transfusion‐dependent β‐thalassemia (TDT): A systematic review
por: Ata, Fateen, et al.
Publicado: (2021)

Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study
por: Li, Xinyu, et al.
Publicado: (2021)

Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial
por: Chen, Jiang-Ming, et al.
Publicado: (2021)

Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients
por: Wijarnpreecha, Karn, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kruualqikbq5fr2tciajh5e3p7